Mortality and morbidity associated with osteoporosis drug treatment following hip fracture

Osteoporosis International

Volumn 14, Issue 9, 2003, Pages 722-727

  Cree, Marilyn W ^a   Juby, Angela G ^a   Carriere, Keumhee C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Elderly; Hip fracture; Morbidity; Mortality; Osteoporosis; Treatment

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; COLECALCIFEROL; CONJUGATED ESTROGEN; ESTRADIOL; ETIDRONIC ACID; MEDROXYPROGESTERONE ACETATE; PIPERAZINE ESTRONE SULFATE; PROGESTERONE; RALOXIFENE; RISEDRONIC ACID; SALCATONIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

AGED; ARTICLE; BONE DENSITY; COLLES FRACTURE; DEMOGRAPHY; FEMALE; HEALTH CARE UTILIZATION; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CALCITONIN; CALCITRIOL; CONTINUITY OF PATIENT CARE; DIPHOSPHONATES; DRUG UTILIZATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HIP FRACTURES; HUMANS; MALE; OSTEOPOROSIS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0142055141     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-003-1430-3     Document Type: Article

References (21)

1. National Osteoporosis Foundation (1989) Report of the Task Force of the National Osteoporosis Foundation: clinical indications for bone mass measurements. J Bone Miner Res 4:1-28
2. Wolinsky FD, Fitzgerald JF, Stump TE (1997) The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. Am J Public Health 87:398-403
3. Marottoli RA, Berkman LF, Cooney LM Jr (1992) Decline in physical function following hip fracture. J Am Geriatr Soc 40:861-866
4. Salkeld G, Cameron ID, Cumming RG et al. (2000) Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ 320:341-346
5. Murphy J, Isaacs B (1982) The post-fall syndrome. A study of 36 elderly patients. Gerontology 28:265-270
6. Hajcsar EE, Hawker G, Bogoch ER (2000) Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ 163:819-822
7. Juby AG, De Geus-Wenceslau CM (2002) Evaluation of osteoporosis in seniors after hip fracture. Osteoporos Int 13:205-210
8. Mainous AG III, Gill JM (1998) The importance of continuity of care in the likelihood of future hospitalization: is site of care equivalent to a primary clinician? Am J Public Health 88:1539-1541
9. Cree M, Soskolne CL, Belseck E et al. (2000) Mortality and institutionalization following hip fracture. J Am Geriatr Soc 48:283-288
10. Steinwachs DM (1979) Measuring provider continuity in ambulatory care: an assessment of alternative approaches. Med Care 18:551-565
11. Wartski SA, Green DS (1971) Evaluation in home-care program. Med Care 9:352-364
12. Dirschl DR, Piedrahita L, Henderson RC (2000) Bone mineral density 6 years after a hip fracture: a prospective, longitudinal study. Bone 26:95-98
13. McClung MR, Geusens P, Miller PD et al. (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333-340
14. Black DM, Cummings SR, Karpf DB et al. (1996) Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research group. Lancet 348:1535-1541
15. Magaziner J, Hawkes W, Hebel JR et al. (2000) Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci 55:M498-M507
16. March LM, Cameron ID, Cumming RG et al. (2000) Mortality and morbidity after hip fracture: can evidence based clinical pathways make a difference? J Rheumatol 27:2227-2231
17. Marottoli RA, Berkman LF, Leo-Summers L et al. (1994) Predictors of mortality and institutionalization after hip fracture: the New Haven EPESE cohort. Established Populations for Epidemiologic Studies of the Elderly. Am J Public Health 84:1807-1812
18. McKercher HG, Crilly RG, Kloseck M (2000) Osteoporosis management in long-term care. Can Fam Phys 46:2228-2235
19. Yuen CK, Kendler D, Khan A, Brown J, Fortier M (2001) Canadian consensus on menopause and osteoporosis: osteoporosis. J Obstet Gynecol Can: XX1-XX11
20. Scientific Advisory Board (1996) Clinical practice guidelines for the diagnosis and management of osteoporosis. CMAJ 155:1113-1133
21. Davis DA, Taylor-Vaisey A (1997) Translating guidelines into practice. CMAJ 157:408-416